微超声与MRI/超声融合活检检测临床显著前列腺癌:倾向加权比较研究
该回顾性研究纳入1119例接受认知靶向微超声引导活检(MB)或MRI/超声融合引导活检(PFB)的男性,经倾向评分加权后比较临床显著前列腺癌(csPCa)检出率。结果显示联合采样时MB的csPCa检出率高于PFB(45% vs 34%),但仅靶向活检时无显著差异,且PFB组前列腺切除术后Gleason升级更常见。
要点
- 联合采样时MB的csPCa检出率高于PFB(45% vs 34%)。
- 仅靶向活检时两种技术检出率无显著差异。
- PFB组前列腺切除术后Gleason升级更频繁(38% vs 17%)。
核心结论
- 调整分析中MB的csPCa检出率更高,但获益并非在所有情况下一致。
研究设计与样本
- 回顾性分析2019至2022年间1119例接受MB(n=767)或PFB(n=352)的男性。
- 采用基于逻辑回归倾向评分的逆概率治疗加权平衡基线特征。
主要发现
- 仅靶向活检时,整体队列及活检初治男性中两种技术无显著差异。
- 前部病变患者中两种技术的csPCa检出率相似。
- 全队列多变量模型中,MB和PI-RADS 5病变与csPCa独立相关。
临床怎么用
- 联合采样时MB可能提高csPCa检出率,但需结合病变位置和活检策略个体化选择。
局限性
- 回顾性设计可能引入选择偏倚,需进一步研究验证获益是否反映方法学优势或情境因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compare the detection rates of clinically significant prostate cancer (csPCa) between cognitively targeted micro-ultrasound-guided biopsy (MB) and MRI/ultrasound fusion-guided biopsy (PFB) in men with MRI-visible lesions. MATERIALS AND METHODS: We retrospectively analyzed 1119 men who underwent MB (n = 767) or PFB (n = 352) between 2019 and 2022. Inverse probability of treatment weighting based on a logistic regression propensity score was applied to balance baseline characteristics between groups. Weighted logistic regression models were used to compare csPCa detection in the overall cohort and in subgroups of biopsy-naïve men and those with anterior lesions. A separate multivariable logistic regression was performed in the full cohort to identify independent predictors of csPCa. Concordance between biopsy and radical prostatectomy Gleason scores was also evaluated. RESULTS: After inverse probability of treatment weighting adjustment, csPCa detection with MB was higher than with PFB in combined sampling (45% vs 34%; odds ratio, 1.61; 95% CI: 1.23-2.11; P < .01). However, no significant difference was observed between techniques for targeted biopsies alone, both in the overall cohort and among biopsy-naïve men. In patients with anterior lesions, csPCa detection rates were also similar. In the full cohort multivariable model, MB and Prostate Imaging-Reporting and Data System 5 lesions were independently associated with csPCa. Gleason upgrading at prostatectomy was more frequent in the PFB group (38% vs 17%; P = .01). CONCLUSIONS: While MB demonstrated higher csPCa detection in adjusted analyses, the benefit was not consistent across all settings. Further studies are warranted to determine whether this reflects a methodological advantage or context-dependent factors.
引用
- Castilho Borges R, Tourinho-Barbosa RR, Dias N, et al. Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound vs Magnetic Resonance Imaging/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study. J Urol. 2025. PMID: 41004641. doi:10.1097/JU.0000000000004793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。